Evercore ISI analyst Umer Raffat notes generics have filed a new district court case against a new Teva Pharma (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE